| Type | Period | Ended | Filed | |
|---|---|---|---|---|
| 10-Q | Q4 2025 | 12/31/25 | 2/4/26 | → |
| 10-K | FY 2025 | 9/30/25 | 11/24/25 | → |
| 10-Q | Q2 2025 | 6/30/25 | 8/5/25 | → |
| 10-Q | Q1 2025 | 3/31/25 | 5/7/25 | → |
| 10-Q | Q4 2024 | 12/31/24 | 2/6/25 | → |
| 10-K | FY 2024 | 9/30/24 | 11/20/24 | → |
| ↓ | ||||
| Filed | Period | |
|---|---|---|
| 2/3/26 | Q2 FY2026 | → |
| 11/3/25 | Q1 FY2026 | → |
| 8/4/25 | Q4 FY2025 | → |
| 5/6/25 | Q3 FY2025 | → |
| 2/4/25 | Q2 FY2025 | → |
| 11/4/24 | Q1 FY2025 | → |
| ↓ | ||
| Filed | Type | Description | |
|---|---|---|---|
| 1/14/26 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 6/3/25 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 3/18/25 | Vote | Submission of Matters to a Vote of Security Holders | → |
| 12/4/24 | Reg FD | Regulation FD Disclosure | → |
| 7/12/24 | Exec Change | Departure or Appointment of Directors or Certain Officers | → |
| 3/13/24 | Vote | Submission of Matters to a Vote of Security Holders | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 1/27/26 | ARS | ARS | → |
| 4/7/25 | S-8 POS | S-8 POS | → |
| 4/7/25 | S-8 POS | S-8 POS | → |
| 4/7/25 | S-8 | S-8 | → |
| 1/24/25 | ARS | ARS | → |
| 3/29/24 | S-8 | S-8 | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 1/27/26 | DEFA14A | DEFA14A | → |
| 1/27/26 | DEF 14A | DEF 14A | → |
| 1/24/25 | DEFA14A | DEFA14A | → |
| 1/24/25 | DEF 14A | DEF 14A | → |
| 1/26/24 | DEFA14A | DEFA14A | → |
| 1/26/24 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 1/12/26 | 4 | 4 | → |
| 1/12/26 | 4 | 4 | → |
| 1/12/26 | 4 | 4 | → |
| 1/12/26 | 4 | 4 | → |
| 1/12/26 | 4 | 4 | → |
| 1/12/26 | 4 | 4 | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 8/14/25 | 144 | 144 | → |
| 6/20/25 | 11-K | FORM 11-K | → |
| 5/12/25 | SCHEDULE 13G/A | SCHEDULE 13G/A | → |
| 11/13/24 | 144 | 144 | → |
| 11/12/24 | 144 | 144 | → |
| 9/3/24 | 144 | 144 | → |
| ↓ | |||
Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.